Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
1.200
-0.010 (-0.83%)
Dec 5, 2025, 4:00 PM EST - Market closed
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $38.47 million as of December 5, 2025. Its market cap has decreased by -72.18% in one year.
Market Cap
38.47M
Enterprise Value
3.48M
1-Year Change
-72.18%
Ranking
Category
Stock Price
$1.20
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $38.47M, a decrease of -89.20%. That is a compound annual growth rate of -74.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 38.80M | -54.83% |
| Dec 31, 2024 | 85.90M | -75.88% |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |